Abingworth — 2017 Investments

3 investments dated 2017 · listed companies and verified rows first · show all

SUTROVAX, INC.sutrovax.comNASDAQ: PCVXMar 2017

Vaxcyte is a biotech company developing vaccines to treat or prevent serious infectious diseases.

BiotechDeep TechHealthtechSouth San Francisco, US

Grant Pickering(Chief Executive Officer, Director and Co-Founder)Jeff Fairman(Vice President of Research and Co-Founder)Ashish Khanna(Executive Officer)

BoardTracy Saxton(Director)William Newell(Director)

Board seatKurt von Emster· per SEC Form D

Co-investorsCTI Life Sciences Fund L.P.Foresite Capital Frazier Life Sciences Janus Henderson Investors Longitude Capital Medicxi +4 more

Nouscomnouscom.comSeries B · Nov 2017 · $49M

Nouscom is a biotech company whose investors page lists its venture capital backers.

BiotechHealthtech

Riccardo Cortese(Co-Founder)Marina Udier(Chief Executive Officer and Board Director)Elisa Scarselli(Chief Scientific Officer and Co-Founder)Alfredo Nicosia(Co-founder)Antonella Folgori(Co-founder)Stefano Colloca(Co-founder)

Co-investors5AM Ventures Andera Partners Angelini Ventures Revelation Partners XGEN Venture Bpifrance +6 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

VirionHealth

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.